Mizuho Securities USA’s Elevance Health ELV Stock Holding History

Mizuho Securities USA’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.91M	Sell	13,343 -2,839	-18%	-$933K	0.09%	246
2025 Q4	$5.47M	Sell	16,182 -218	-1%	-$73.7K	0.09%	187
2025 Q3	$5.23M	Buy	16,400 +785	+5%	+$244K	0.11%	190
2025 Q2	$6.07M	Sell	15,615 -2,955	-16%	-$1.19M	0.13%	158
2025 Q1	$8.08M	Sell	18,570 -3,411	-16%	-$1.37M	0.17%	113
2024 Q4	$8.11M	Buy	21,981 +6,944	+46%	+$2.91M	0.15%	126
2024 Q3	$7.82M	Sell	15,037 -2,885	-16%	-$1.54M	0.17%	98
2024 Q2	$9.71M	Buy	+17,922	New	+$9.47M	0.21%	85
2017 Q1	–	Sell	-9,400	Closed	-$1.35M	–	181
2016 Q4	$1.35M	Buy	+9,400	New	+$1.26M	0.06%	97

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Mizuho Securities USA's ELV Position: Q1 2026 in Review

Mizuho Securities USA reduced its Elevance Health (ELV) stake by 18% in Q1 2026, selling an estimated $933K and leaving 13,343 shares worth $3.91M. The position accounts for 0.09% of the portfolio, ranked #246.

Mizuho Securities USA first reported a position in ELV in Q4 2016 and has held it in 9 quarters since. The position peaked at $9.71M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Mizuho Securities USA held 13,343 shares of Elevance Health worth $3.91M as of Q1 2026.
Mizuho Securities USA sold 2,839 Elevance Health shares in Q1 2026, an estimated $933K.
Elevance Health made up 0.09% of Mizuho Securities USA's portfolio in Q1 2026, its #246 holding.
Mizuho Securities USA first reported a position in Elevance Health in Q4 2016 and has held it in 9 quarters since.
Mizuho Securities USA's Elevance Health position peaked at $9.71M in Q2 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Mizuho Securities USA's 13F filing for Q1 2026, filed 11 May 2026.